Huaxi Securities believes that in 2025, A-share earnings are expected to usher in an inflection point, with a high probability of technological growth assets, and revenue growth is expected to become the dominant factor in style allocation. The short-term "New Year's Market" has been launched, focusing on the value direction of the market before the year, and looking at the two main lines of domestic demand and advanced manufacturing after the year. It is expected that A shares will remain in a volatile state, and the "New Year's Market" configuration has a high winning rate.The big consumption sector has become the strongest main line of the market.On the disk, the big consumer sector led the rise all day, with retail, ice and snow tourism, food and beverage, household items and other directions rising sharply; Real estate stocks performed in intraday trading, with Tiandiyuan and Hualian shares trading daily; The pharmaceutical biological sector was active at the beginning of the session, with Haixin shares, First Medicine and Panlong Pharmaceutical trading daily.
A shares fluctuated higher, and the large consumer sector collectively strengthened.Ping An Securities judges that the growth style of A-share market will be more flexible in 2025, and structural investment opportunities will increase.Ping An Securities judges that the growth style of A-share market will be more flexible in 2025, and structural investment opportunities will increase.
Ping An Securities judges that the growth style of A-share market will be more flexible in 2025, and structural investment opportunities will increase.A shares fluctuated higher, and the large consumer sector collectively strengthened.On the disk, the big consumer sector led the rise all day, with retail, ice and snow tourism, food and beverage, household items and other directions rising sharply; Real estate stocks performed in intraday trading, with Tiandiyuan and Hualian shares trading daily; The pharmaceutical biological sector was active at the beginning of the session, with Haixin shares, First Medicine and Panlong Pharmaceutical trading daily.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13